TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10941877

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (0.58 g EPA plus 1.67 g DHA per day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Linseed oil supplementation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Two most concentrated fish oil supplements
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Linseed oil and fish oil supplements
Number of subjects: 48
Study: 9213798

Group type: EXPERIMENTAL
Intervention: Preferential posture in infants
Number of subjects: 7609

Group type: COMPARATOR
Intervention: Control group (infants without preferential posture)
Number of subjects: 7609
Study: 7966728

Group type: EXPERIMENTAL
Intervention: Acute bacterial prostatitis
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Chronic bacterial prostatitis
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Abacterial prostatitis
Number of subjects: 106
Study: 3305460

Group type: EXPERIMENTAL
Intervention: Tobramycin and cefuroxime
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 52
Study: 30910492

Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg orally, once daily 3 times a week for 2 years)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 89
Study: 30429496

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ADR-1
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ADR-3
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ADR-1 and ADR-3
Number of subjects: 68
Study: 26938813

Group type: EXPERIMENTAL
Intervention: Blood pressure-lowering medication (fixed combination of perindopril and indapamide)
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11140
Study: 24215848

Group type: EXPERIMENTAL
Intervention: Bevacizumab added to capecitabine monotherapy
Number of subjects: 0
Study: 22433778

Group type: EXPERIMENTAL
Intervention: Three doses of sulphadoxine‐pyrimethamine (SP)
Number of subjects: 1034

Group type: COMPARATOR
Intervention: Two doses of sulphadoxine‐pyrimethamine (SP)
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: First trimester malaria infection
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Second trimester malaria infection
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: First trimester malaria infection (adjusted)
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Maternal anaemia and perinatal mortality
Number of subjects: 1034
Study: 18688720

Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 17227729

Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (non-porotic healthy women)
Number of subjects: 59
Study: 15296819

Group type: EXPERIMENTAL
Intervention: placebo/desipramine (50 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: placebo/haloperidol (2 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: desipramine (50 mg)/haloperidol (2 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: desipramine (50 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: haloperidol (2 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo/placebo
Number of subjects: 12
Study: 10891977

Group type: EXPERIMENTAL
Intervention: High-dose creatine (150 mg/kg body weight) followed by low-dose creatine (60 mg/kg)
Number of subjects: 9
Study: 9376578

Group type: EXPERIMENTAL
Intervention: Autologous Bone Marrow Transplantation (BMT)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Intensive Consolidation Chemotherapy (ICC)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Allogeneic Bone Marrow Transplantation (BMT)
Number of subjects: 367

Group type: COMPARATOR
Intervention: No HLA-identical sibling (control group)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Autologous BMT
Number of subjects: 367

Group type: COMPARATOR
Intervention: ICC
Number of subjects: 367
Study: 1403756

Group type: EXPERIMENTAL
Intervention: 1% acetylcholine chloride
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.01% carbachol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Balanced salt solution (control)
Number of subjects: 90
Study: 4055108

Group type: EXPERIMENTAL
Intervention: Plasma exchange and hemodialysis
Number of subjects: 19

Group type: COMPARATOR
Intervention: Peritoneal dialysis
Number of subjects: 19
Study: 3579066

Group type: EXPERIMENTAL
Intervention: Treadmill exercise test
Number of subjects: 2842

Group type: EXPERIMENTAL
Intervention: Treadmill score of -11 or less
Number of subjects: 2842

Group type: EXPERIMENTAL
Intervention: Treadmill score of +7 or more
Number of subjects: 2842
Study: 31648883

Group type: EXPERIMENTAL
Intervention: Omega-6 levels
Number of subjects: 184305

Group type: COMPARATOR
Intervention: TC, LDL-C, TG
Number of subjects: 184305
Study: 31333778

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy combined with radiotherapy
Number of subjects: 400
Study: 28570792

Group type: EXPERIMENTAL
Intervention: Tai Chi intervention
Number of subjects: 67

Group type: COMPARATOR
Intervention: Education program
Number of subjects: 67

Group type: COMPARATOR
Intervention: Waitlisted group
Number of subjects: 67
Study: 26347091

Group type: EXPERIMENTAL
Intervention: Nonpneumatic antishock garment (NASG) added to standard hemorrhage management
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Nonpneumatic antishock garment (NASG)
Number of subjects: 953
Study: 24118234

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplements during pregnancy
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Fish oil supplements during pregnancy
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Azithromycin for acute lung symptoms in children with recurrent wheeze
Number of subjects: 738
Study: 21421766

Group type: EXPERIMENTAL
Intervention: Praying for a stranger
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Praying for the person who angered them
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Praying for a friend in need
Number of subjects: 0
Study: 18718924

Group type: EXPERIMENTAL
Intervention: Telephone contact plus questionnaire
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Telephone contact only
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Questionnaire only
Number of subjects: 560

Group type: COMPARATOR
Intervention: Neither
Number of subjects: 560
Study: 16507855

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1010
Study: 14504022

Group type: EXPERIMENTAL
Intervention: Lofexidine/naloxone
Number of subjects: 89

Group type: COMPARATOR
Intervention: Lofexidine/placebo
Number of subjects: 89
Study: 10709749

Group type: EXPERIMENTAL
Intervention: Exiting using steps and grab-rails
Number of subjects: 10

Group type: COMPARATOR
Intervention: Exiting from cab-level or trailer-level
Number of subjects: 10
Study: 9448971

Group type: EXPERIMENTAL
Intervention: Local data management provision
Number of subjects: 0
Study: 8402096

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Plain abdominal radiography
Number of subjects: 16

Group type: COMPARATOR
Intervention: Abdominal ultrasonography
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Laparotomy
Number of subjects: 16
Study: 2937703

Group type: EXPERIMENTAL
Intervention: Thrombolysis without PTCA
Number of subjects: 127

Group type: COMPARATOR
Intervention: Thrombolysis with PTCA
Number of subjects: 127
Study: 30101329

Group type: EXPERIMENTAL
Intervention: FAB (promotion of breastfeeding, healthy eating, physical activity: 8 contacts, antenatal, 18 mo)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Sleep (prevention of sleep problems: antenatal, 3 wk)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Combination (both interventions)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 802
Study: 26610166

Group type: EXPERIMENTAL
Intervention: Oxycodone treatment for 5 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oxycodone treatment
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oxycodone treatment with secretagogues (PGE2, theophylline, ouabain)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Morphine application
Number of subjects: 25
Study: 24034178

Group type: EXPERIMENTAL
Intervention: 100% oxygen dive
Number of subjects: 26

Group type: COMPARATOR
Intervention: Compressed air dive
Number of subjects: 26
Study: 22172434

Group type: EXPERIMENTAL
Intervention: Tenecteplase plus heparin
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 1000
Study: 20858697

Group type: EXPERIMENTAL
Intervention: SET plus hypocaloric diet for 6 weeks (Group C)
Number of subjects: 96

Group type: COMPARATOR
Intervention: SET plus hypocaloric diet for 6 weeks (Group A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 2 weeks of observation followed by one cycle of CC therapy (Group B)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SET plus hypocaloric diet for 6 weeks (Groups A and C)
Number of subjects: 96
Study: 18954289

Group type: EXPERIMENTAL
Intervention: Electric scooter simulation intervention group
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 16822627

Group type: EXPERIMENTAL
Intervention: Dietary intervention group (IG) with biweekly nutrition education and low-fat, fortified dairy products
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Dietary intervention group (IG)
Number of subjects: 82
Study: 12930613

Group type: EXPERIMENTAL
Intervention: Mebendazole (200 mg three times daily for 3 days)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Secnidazole (30 mg/kg, in a single dose)
Number of subjects: 146
Study: 10807711

Group type: EXPERIMENTAL
Intervention: Artificial bilayer membrane grafted in 8 patients
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard closure by suture in 5 patients (control group)
Number of subjects: 13
Study: 8656366

Group type: EXPERIMENTAL
Intervention: 3.5 mm incision (Group A)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 5.0 mm incision (Group B)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 58
Study: 1458765

Group type: EXPERIMENTAL
Intervention: 0.2mg moxonidine twice daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: 0.2mg digoxin once daily
Number of subjects: 15
Study: 3881122

Group type: EXPERIMENTAL
Intervention: External cephalic version attempted in 310 patients
Number of subjects: 640

Group type: COMPARATOR
Intervention: Control group (330 patients, version not attempted)
Number of subjects: 640
Study: 29743128

Group type: EXPERIMENTAL
Intervention: ω‐3 only
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: ω‐3 + social skills
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: social skills only
Number of subjects: 282

Group type: COMPARATOR
Intervention: placebo control
Number of subjects: 282
Study: 27997679

Group type: EXPERIMENTAL
Intervention: Ledipasvir-sofosbuvir (90 mg ledipasvir and 400 mg sofosbuvir once daily for 12 weeks)
Number of subjects: 100
Study: 26345320

Group type: EXPERIMENTAL
Intervention: Youth Readiness Intervention (YRI)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 436
Study: 25054452

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (3.0 g/day of EPA and DHA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 30
Study: 22243363

Group type: EXPERIMENTAL
Intervention: Losartan-based treatment
Number of subjects: 8586

Group type: COMPARATOR
Intervention: Atenolol-based treatment
Number of subjects: 8586

Group type: EXPERIMENTAL
Intervention: In-treatment serum K ≤ 3.90
Number of subjects: 8586
Study: 19544230

Group type: COMPARATOR
Intervention: Modified Menghini-type needle (MMT)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Tru-cut-type needle (TCT)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Combination of cytology and histology
Number of subjects: 307
Study: 17947724

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 1614

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 1614

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 1614
Study: 14872275

Group type: EXPERIMENTAL
Intervention: CISS (Constructive Interference in Steady State)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: True-FISP (True Fast Imaging in Steady State Precession)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: T1-weighted spin-echo (T1SE)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Interobserver analysis
Number of subjects: 101

Group type: COMPARATOR
Intervention: Chest Radiography (CR)
Number of subjects: 101
Study: 11878178

Group type: EXPERIMENTAL
Intervention: Occupational therapy with technical accessories and splints
Number of subjects: 33
Study: 9747912

Group type: EXPERIMENTAL
Intervention: Rilmenidine (1-2 mg/day)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Nifedipine (40 mg/day)
Number of subjects: 73
Study: 8155207

Group type: EXPERIMENTAL
Intervention: Curosurf (natural surfactant)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 3076795

Group type: EXPERIMENTAL
Intervention: Methyldopa (750 mg daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 30024488

Group type: EXPERIMENTAL
Intervention: Bilateral lower leg heating (LLH) via water bath immersion at 42°C for 15 minutes
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bilateral lower leg heating (LLH) via water bath immersion at 42°C for 45 minutes
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no heating)
Number of subjects: 6
Study: 28258828

Group type: EXPERIMENTAL
Intervention: DNA-TGN concentration during maintenance therapy
Number of subjects: 918

Group type: EXPERIMENTAL
Intervention: Erythrocyte concentrations of TGN, methylated mercaptopurine metabolites, and methotrexate polyglutamates
Number of subjects: 918
Study: 25881117

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 44
Study: 24390682

Group type: EXPERIMENTAL
Intervention: Theory before simulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Simulation before theory
Number of subjects: 20
Study: 23041713

Group type: EXPERIMENTAL
Intervention: Electrical acupoint stimulation (EAS) at maximal intensity without pain
Number of subjects: 40

Group type: COMPARATOR
Intervention: Minimal-EAS at a just detectable intensity
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comparison between EAS and minimal-EAS
Number of subjects: 40
Study: 19503783

Group type: EXPERIMENTAL
Intervention: Risedronate 150 mg once a month
Number of subjects: 0
Study: 17718644

Group type: EXPERIMENTAL
Intervention: Dry needling of trigger points and paraspinal needling
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dry needling of trigger points only
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 15186934

Group type: EXPERIMENTAL
Intervention: Ivermectin (150-200 microg/kg body weight)
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: Ivermectin (150-200 microg/kg body weight) + Albendazole (400 mg)
Number of subjects: 1829

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 1829
Study: 11753309

Group type: EXPERIMENTAL
Intervention: Control of bias at entry
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Control of bias in assessment of outcome
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Control of bias after entry
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Overall quality scores
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Method of randomization
Number of subjects: 62
Study: 9667292

Group type: EXPERIMENTAL
Intervention: Meperidine (0.15, 0.30, or 0.60 microg/ml)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sufentanil (0.1, 0.15, or 0.2 ng/ml)
Number of subjects: 30
Study: 9075462

Group type: EXPERIMENTAL
Intervention: Intrathecal protirelin (500 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham lumbar puncture procedure
Number of subjects: 8
Study: 2117932

Group type: EXPERIMENTAL
Intervention: Ultrasound scanning within 48 hours of injury
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Ultrasound scanning
Number of subjects: 114
Study: 6783707

Group type: EXPERIMENTAL
Intervention: Sequential study (6 persons subinoculated with malaria-rich blood)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Prospective study (15 volunteers receiving malaria-rich blood from 14 different donors)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Overall findings from both studies
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 21
Study: 31558345

Group type: EXPERIMENTAL
Intervention: Reticular pseudodrusen (RPD) presence
Number of subjects: 2516
Study: 28180985

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 9

Group type: COMPARATOR
Intervention: ACV
Number of subjects: 9
Study: 26551196

Group type: EXPERIMENTAL
Intervention: Povidone-iodine with alcohol
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Chlorhexidine with alcohol
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Sequential combination of both solutions
Number of subjects: 1404

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1404
Study: 25886386

Group type: EXPERIMENTAL
Intervention: Astragaloside IV (AS-IV) treatment
Number of subjects: 4

Group type: COMPARATOR
Intervention: 4-phenyl butyric acid (PBA) treatment
Number of subjects: 4

Group type: COMPARATOR
Intervention: Normal control (Normal group)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Diabetic nephropathy (Model group)
Number of subjects: 4
Study: 24014917

Group type: EXPERIMENTAL
Intervention: Statin medication (Group-I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No statin medication (Group-II)
Number of subjects: 30
Study: 21922033

Group type: EXPERIMENTAL
Intervention: Monetary rewards during approach sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avoid monetary losses during avoidance sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative reinforcer presence
Number of subjects: 0
Study: 19748656

Group type: EXPERIMENTAL
Intervention: laropiprant 300 mg/d for 3 weeks
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: laropiprant plus montelukast 10 mg/d for 2 weeks
Number of subjects: 867

Group type: COMPARATOR
Intervention: montelukast
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: laropiprant 25 mg/d or 100 mg/d
Number of subjects: 867

Group type: COMPARATOR
Intervention: cetirizine 10 mg/d
Number of subjects: 867

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 867
Study: 16522757

Group type: EXPERIMENTAL
Intervention: Case-based seminar with a behavioral science instructor
Number of subjects: 204

Group type: COMPARATOR
Intervention: Case-based seminar without a behavioral science instructor
Number of subjects: 204
Study: 14701888

Group type: EXPERIMENTAL
Intervention: Educational outreach visits (EOVs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mailout strategies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 11045796

Group type: EXPERIMENTAL
Intervention: 5 grams of ground flaxseed per day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 10 grams of ground flaxseed per day
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0 grams of ground flaxseed per day
Number of subjects: 31
Study: 10099062

Group type: EXPERIMENTAL
Intervention: Metoclopramide plus labetalol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Labetalol alone
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 11
Study: 7976777

Group type: EXPERIMENTAL
Intervention: Ornithine oxoglutarate (OGO)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 2700991

Group type: EXPERIMENTAL
Intervention: Blue-green argon laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Monochromatic green argon laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Yellow dye laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 1146928

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol or mestranol (50 to 100 mug per day)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol or mestranol with 2.5 mg norethindrone acetate, 2 mg megestrol acetate, or 0.5 mg norgestrel
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol or mestranol (various doses)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol or mestranol with progestational agent
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol (50 mug per day)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Long-term oral contraceptives
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Estrogen agents (50 to 75 mug per day)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Normal controls (IUD cycles) and chronic treatment with oral contraceptives
Number of subjects: 191
Study: 31332029

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 IU b.i.d. plus pioglitazone 45 mg/day
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 IU b.i.d.
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 29231585

Group type: EXPERIMENTAL
Intervention: Acupuncture plus western medicine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Comparison of both groups after treatment
Number of subjects: 76
Study: 26672701

Group type: EXPERIMENTAL
Intervention: Customized plastic shield on brackets
Number of subjects: 42

Group type: COMPARATOR
Intervention: No shield on brackets
Number of subjects: 42